UK markets close in 6 hours 24 minutes

XTL Biopharmaceuticals Ltd. (XTLB)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.5300+0.0900 (+3.69%)
At close: 04:00PM EDT
2.5700 +0.04 (+1.58%)
After hours: 07:45PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
31
31
30
30
38
Selling general and administrative
734
734
850
1,001
910
Total operating expenses
765
765
880
1,031
948
Operating income or loss
-765
-765
-880
-1,031
-948
Total other income/expenses net
-1,054
-1,054
-493
1,479
-2,022
Income before tax
-1,782
-1,782
-1,348
435
-2,954
Income from continuing operations
-1,782
-1,782
-1,348
435
-2,954
Net income
-1,782
-1,782
-1,348
435
-2,954
Net income available to common shareholders
-1,782
-1,782
-1,348
435
-2,954
Basic EPS
-0.40
-
-0.20
0.10
-0.60
Diluted EPS
-0.40
-
-0.20
-0.04
-0.60
Basic average shares
5,449
-
5,449
5,320
5,142
Diluted average shares
5,449
-
5,449
6,155
5,142